Replies to post #570188 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Poor Man, I think you may be confused. Flaskworks was sold to NWBio in 2020.

[SkyLimit2022]

Thanks for posting. It’s easy to get distracted from the science of the murcidencel platform technology, but the shiny objects are no match for living patients!

https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/

This video celebrated a DCVax survivor years ago. She was 24 at diagnosis and now in 2023 has reached another 24 years of life as a GBM survivor. Congratulations!

There is nothing more currently relevant and astonishing than old, old, old news about a GBM patient. This video is over a decade old!

https://www.hawaii.edu/news/2017/03/30/newirth-laker-for-a-day/

https://www.theguardian.com/science/2022/nov/17/im-just-carrying-on-vaccine-gives-brain-cancer-patient-years-of-extra-life

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

[norisknorewards]

Lol, amazing. But as I stated, this is your fabrication, no one else's. There is no fiasco

[VMLG17]

PM, you stated that you “guessed” the month was removed on SM’s LinkedIn information at the company’s request and then concluded that the level of of lying and gas lighting by the company was astounding. I am astounded that any former executive would slander another executive based on a guess. My guess is that your constant disparagement of the company is because tearing down others covers your own insecurities concerning what a failure you were in your own career. I assume you are okay being on the receiving end of someone else’s guesses.

[Maverick0408]

Your point about company’s transparency and business ethics is spot on. There is no denying that they fail big time in those aspects. No wonder they are unable to get big, credible partner or investors on board.

However, I haven’t followed SM’s departure saga if that is indeed true. Although, I am not too concerned if he left sometimes last year. The silver lining is he stayed at least 2 years with the company and that’s really significant in these cases. Such science driven independent founders typically move on to other projects and besides don’t like being tied too much to a narrow set of commercial and regulatory objectives for too long. I have seen and experienced this a lot in medical device M&A space.

[JimSmith111]

This is an extreme overreaction.

But worse, the reaction is to a fake scenario that is not real.